1. Ben-Shabat, S., Fride, E., Sheskin, T., Tamiri, T., Rhee, M. H., Vogel, Z., Bisogno, T., De Petrocellis, L., Di Marzo, V. and Mechoulam, R. (1998) An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity.
Eur. J. Pharmacol., 353: 23-31.
[PMID:9721036]
2. Bouaboula, M., Bourri&e&, B., Rinaldi-Carmona, M., Shire, D., LeFur, G. and Casellas, P. (1995) Stimulation of cannabinoid receptor CB1induceskrox-24expression in human astrocytoma cells.
J. Biol. Chem., 270: 13973-13980.
[PMID:7775459]
3. Bouaboula, M., Poinot-Chazel, C., Bourrie, B., Canat, X., Calandra, B., Rinaldi-Carmona, M., Le Fur, G. and Casellas, P. (1995) Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1.
Biochem. J., 312: 637-641.
[PMID:8526880]
4. Breivogel, C. S., Sim, L. J. and Childers, S. R. (1997) Regional differences in cannabinoid receptor/G-protein coupling in rat brain.
J. Pharmacol. Exp. Ther., 282: 1632-1642.
[PMID:9316881]
5. Chakrabarti, A., Onaivi, E. S. and Chaudhuri, G. (1995) Cloning and sequencing of a cDNA encoding the mouse brain-type cannabinoid receptor protein.
DNA Seq., 5: 385-388.
[PMID:8777318]
6. Childers, S. R. and Deadwyler, S. A. (1996) Role of cyclic AMP in the actions of cannabinoid receptors.
Biochem. Pharmacol., 52: 819-827.
[PMID:8781498]
7. Chin, C. N., Lucas-Lenard, J., Abadji, V. and Kendall, D. A. (1998) Ligand binding and modulation of cyclic AMP levels depend on the chemical nature of residue 192 of the human cannabinoid receptor 1.
J. Neurochem., 70: 366-373.
[PMID:9422383]
8. Devane, W. A., Breuer, A., Sheskin, T., Jarbe, T. U. C., Eisen, M. S. and Mechoulam, R. (1992) A novel probe for the cannabinoid receptor.
J. Med. Chem., 35: 2065-2069.
[PMID:1317925]
9. Di Marzo, V., Bisogno, T., De Petrocellis, L., Brandi, I., Jefferson, R. G., Winckler, R. L., Davis, J. B., Dasse, O., Mahadevan, A., Razdan, R. K. and Martin, B. R. (2001) Highly selective CB1 cannabinoid receptor ligands and novel CB1/VR1 vanilloid receptor "hybrid" ligands.
Biochem. Biophys. Res. Commun., 281: 444-451.
[PMID:11181068]
10. Dove Pettit, D. A., Harrison, M. P., Olson, J. M., Spencer, R. F. and Cabral, G. A. (1998) Immunohistochemical localization of the neural cannabinoid receptor in rat brain.
J. Neurosci. Res., 51: 391-402.
[PMID:9486774]
11. Felder, C. C., Joyce, K. E., Briley, E. M., Glass, M., Mackie, K. P., Fahey, K. J., Cullinan, G. J., Hunden, D. C., Johnson, D. W., Chaney, M. O., Koppel, G. A. and Brownstein, M. (1998) LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation.
J. Pharmacol. Exp. Ther., 284: 291-297.
[PMID:9435190]
12. Felder, C. C., Joyce, K. E., Briley, E. M., Mansouri, J., Mackie, K., Blond, O., Lai, Y., Ma, A. L and Mitchell, R. L. (1995) Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
Mol. Pharmacol., 48: 443-450.
[PMID:7565624]
13. Felder, C. C., Veluz, J. S., Williams, H. L., Briley, E. M. and Matsuda, L. A. (1992) Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones.
Mol. Pharmacol., 42: 838-845.
[PMID:1331766]
14. Galiegue, S., Mary, S., Marchand, J., Dussossoy, D., Carriere, D., Carayon, P., Bouaboula, M., Shire, D., Le Fur, G. and Casellas, P. (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations.
Eur. J. Biochem., 232: 54-61.
[PMID:7556170]
15. Gatley, S. J., Lan, R., Pyatt, B., Gifford, A. N., Volkow, N. D. and Makriyannis, A. (1997) Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors.
Life Sci., 61: PL191-197.
[PMID:9335234]
16. Gebremedhin, D., Lange, A. R., Campbell, W. B., Hillard, C. J. and Harder, D. R. (1999) Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current.
Am. J. Physiol., 276: 2085-2093.
[PMID:10362691]
17. Gerard, C. M., Mollereau, C., Vassart, G. and Parmentier, M. (1991) Molecular cloning of a human cannabinoid receptor which is also expressed in testis.
Biochem. J., 279: 129-134.
[PMID:1718258]
18. Gerard, C., Mollereau, C., Vassart, G. and Parmentier, M. (1990) Nucleotide sequence of a human cannabinoid receptor cDNA.
Nucleic Acids Res., 18: 7142---.
[PMID:2263478]
19. Glass, M. and Felder, C. C. (1997) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor.
J. Neurosci., 17: 5327-5333.
[PMID:9204917]
20. Henry, D. J. and Chavkin, C. (1995) Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors inXenopusoocytes.
Neurosci. Lett., 186: 91-94.
[PMID:7777206]
21. Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R. and Rice, K. C. (1990) Cannabinoid receptor localization in brain.
Proc. Natl. Acad. Sci. U.S.A., 87: 1932-1936.
[PMID:2308954]
22. Hillard, C. J., Manna, S., Greenberg, M. J., DiCamelli, R., Ross, R. A., Stevenson, L. A., Murphy, V., Pertwee, R. G. and Campbell, W. B. (1999) Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1).
J. Pharmacol. Exp. Ther., 289: 1427-1433.
[PMID:10336536]
23. Hirst, R. A., Almond, S. L. and Lambert, D. G. (1996) Characterisation of the rat cerebella CB1 receptor using SR141716A, a central cannabinoid receptor antagonist.
Neurosci. Lett., 220: 101-104.
[PMID:8981483]
24. Hoehe, M. R., Caenazzo, L., Martinez, M. M., Hsieh, W. T., Modi, W. S., Gershon, E. S. and Bonner, T. I. (1991) Genetic and physical mapping of the human cannabinoid receptor gene to chromosome 6q14-q15.
New Biol., 3: 880-885.
[PMID:1931832]
25. Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., Mechoulam, R. and Pertwee, R. G. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors.
Pharmacol. Rev., 54: 161-202.
[PMID:12037135]
26. Howlett, A. C., Qualy, J. M. and Khachatrian, L. L. (1986) Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs.
Mol. Pharmacol., 29: 307-313.
[PMID:2869405]
27. Jansen, E. M., Haycock, D. A., Ward, S. J. and Seybold, V. S. (1992) Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles.
Brain Res., 575: 93-102.
[PMID:1504787]
28. Jung, M., Calassi, R., Rinaldi Carmona, M., Chardenot, P., Le Fur, G., Soubrie, P. and Oury-Donat, F. (1997) Characterization of CB1 receptors on rat neuronal cell cultures: binding and functional studies using the selective receptor antagonist SR 141716A.
J. Neurochem., 68: 402-409.
[PMID:8978752]
29. Khanolkar, AD; Abadji, V; Lin, S; Hill, WA; Taha, G; Abouzid, K; Meng, Z; Fan, P; Makriyannis, A. (1996) Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand.
J. Med. Chem., 39 (22): 4515-9.
[PMID:8893848]
30. Lan, R., Gatley, J., Lu, Q., Fan, P., Fernando, S. R., Volkow, N. D., Pertwee, R. and Makriyannis, A. (1999) Design and synthesis of the CB1 selective cannabinoid antagonist AM281: a potential human SPECT ligand.
AAPS Pharmsci., 1: E4-null.
[PMID:11741201]
31. Lan, R; Liu, Q; Fan, P; Lin, S; Fernando, SR; McCallion, D; Pertwee, R; Makriyannis, A. (1999) Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists.
J. Med. Chem., 42 (4): 769-76.
[PMID:10052983]
32. Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J. F., Beslot, F., Bohme, G. A., Imperato, A., Pedrazzini, T., Roques, B. P., Vassart, G., Fratta, W. and Parmentier, M. (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.
Science, 283: 401-404.
[PMID:9888857]
33. Mackie, K. and Hille, B. (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells.
Proc. Natl. Acad. Sci. U.S.A., 89: 3825-3829.
[PMID:1315042]
34. Mackie, K., Lai, Y., Westenbroek, R. and Mitchell, R. (1995) Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor.
J. Neurosci., 15: 6552-6561.
[PMID:7472417]
35. Mailleux, P., Parmentier, M. and Vanderhaeghen, J. J. (1992) Distribution of cannabinoid receptor messenger RNA in the human brain: an in situ hybridization histochemistry with oligonucleotides.
Neurosci. Lett., 143: 200-204.
[PMID:1436667]
36. Martin, B. R., Compton, D. R., Thomas, B. F., Prescott, W. R., Little, P. J., Razdan, R. K., Johnson, M. R., Melvin, L. S., Mechoulam, R. and Ward, S. J. (1991) Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs.
Pharmacol. Biochem. Behav., 40: 471-478.
[PMID:1666911]
37. Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C. and Bonner, T. I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA.
Nature, 346: 561-564.
[PMID:2165569]
38. Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R. et al.. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.
Biochem. Pharmacol., 50: 83-90.
[PMID:7605349]
39. Pacheco, M., Childers, S. R., Arnold, R., Casiano, F. and Ward, S. J. (1991) Aminoalkylindoles: actions on specific G-protein-linked receptors.
J. Pharmacol. Exp. Ther., 257: 170-183.
[PMID:1902257]
40. Pertwee, R. G. (1997) Pharmacology of cannabinoid CB1 and CB2 receptors.
Pharmacol. Ther., 74: 129-180.
[PMID:9336020]
41. Pertwee, R. G. (1999) Pharmacology of cannabinoid receptor ligands.
Curr. Med. Chem., 6: 635-664.
[PMID:10469884]
42. Petitet, F., Marin, L. and Doble, A. (1996) Biochemical and pharmacological characterization of cannabinoid binding sites using [3H]SR141716A.
Neuroreport, 7: 789-792.
[PMID:8733746]
43. Rhee, M.-H., Bayewitch, M., Avidor-Reiss, T., Levy, R. and Vogel, Z. (1998) Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes.
J. Neurochem., 71: 1525-1534.
[PMID:9751186]
44. Rinaldi-Carmona, M., Barth, F., Heaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D. et al.. (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.
FEBS Lett., 350: 240-244.
[PMID:8070571]
45. Rinaldi-Carmona, M., Pialot, F., Congy, C., Redon, E., Barth, F., Bachy, A., Breliere, J. C., Soubrie, P. and Le Fur, G. (1996) Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain.
Life Sci., 58: 1239-1247.
[PMID:8614277]
46. Ross, R. A., Brockie, H. C., Fernando, S. R., Saha, B., Razdan, R. K. and Pertwee, R. G. (1998) Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine.
Br. J. Pharmacol., 125: 1345-1351.
[PMID:9863666]
47. Ross, R. A., Brockie, H. C., Stevenson, L. A., Murphy, V. L., Templeton, F., Makriyannis, A. and Pertwee, R. G. (1999) Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656 and AM630.
Br. J. Pharmacol., 126: 665-672.
[PMID:10188977]
48. Shire, D., Calandra, B., Delpech, M., Dumont, X., Kaghad, M., Le Fur, G., Caput, D. and Ferrara, P. (1996) Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A.
J. Biol. Chem., 271: 6941-6946.
[PMID:8636122]
49. Shire, D., Calandra, B., Rinaldi-Carmona, M., Oustric, D., Pessegue, B., Bonnin-Cabanne, O., Le Fur, G., Caput, D. and Ferrara, P. (1996) Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor.
Biochim. Biophys. Acta, 1307: 132-136.
[PMID:8679694]
50. Shire, D., Carillon, C., Kaghad, M., Calandra, B., Rinaldi-Carmona, M., Le Fur, G., Caput, D. and Ferrara, P. (1995) An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing.
J. Biol. Chem., 270: 3726-3731.
[PMID:7876112]
51. Showalter, V. M., Compton, D. R., Martin, B. R. and Abood, M. E. (1996) Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): Identification of cannabinoid receptor subtype selective ligands.
J. Pharmacol. Exp. Ther., 278: 989-999.
[PMID:8819477]
52. Sim, L. J., Hampson, R. E., Deadwyler, S. A. and Childers, S. R. (1996) Effects of chronic treatment with Δ9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPγS autoradiography in rat brain.
J. Neurosci., 16: 8057-8066.
[PMID:8987831]
53. Song, Z. H. and Bonner, T. I. (1996) A lysine residue of the cannabinoid receptor is critical for receptor recognition by several agonists but not WIN55212-2. .
Mol. Pharmacol., 49: 891-896.
[PMID:8622639]
54. Sugiura, T., Kodaka, T., Kondo, S., Tonegawa, T., Nakane, S., Kishimoto, S., Yamashita, A. and Waku, K. (1996) 2-Arachidonoylglycerol, a putative endogenous cannabinoid receptor ligand, induces rapid, transient elevation of intracellular free Ca2+in neuroblastoma X glioma hybrid NG108-15 cells.
Biochem. Biophys. Res. Commun., 229: 58-64.
[PMID:8954083]
55. Thomas, B. F., Gilliam, A. F., Burch, D. F., Roche, M. J. and Seltzman, H. H. (1998) Comparative receptor binding analyses of cannabinoid agonists and antagonists.
J. Pharmacol. Exp. Ther., 285: 285-292.
[PMID:9536023]
56. Thomas, B. F., Wei, X. and Martin, B. R. (1992) Characterization and autoradiographic localization of the cannabinoid binding site in rat brain using [3H]11-OH-Δ9-THC-DMH.
J. Pharmacol. Exp. Ther., 263: 1383-1390.
[PMID:1335065]
57. Tsou, K., Brown, S., Sanudo-Pena, M. C., Mackie, K. and Walker, J. M. (1998) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system.
Neuroscience, 83: 393-411.
[PMID:9460749]
58. Twitchell, W., Brown, S. and Mackie, K. (1997) Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons.
J. Neurophysiol., 78: 43-50.
[PMID:9242259]
59. Wiley, J. L. and Martin, B. R. (2003) Cannabinoid pharmacological properties common to other centrally acting drugs.
Eur. J. Pharmacol., 471: 185-193.
[PMID:12826237]
60. Zimmer, A., Zimmer, A. M., Hohmann, A.G., Herkenham, M. and Bonner, T. I. (1999) Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.
Proc. Natl. Acad. Sci. U.S.A., 96: 5780-5785.
[PMID:10318961]
Annotated and expert reviewed. Please contact us if you can help with updates.
